CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority reviewPUBT·Jul 27 at 07:58 AM01093+0.12%300765+5.58%
CSPC PHARMA Expects Interim Consolidated Profit of Approximately RMB5.9B-6.2BAASTOCKS News·Jul 27 at 04:44 AM01093+0.12%300765+5.58%
CSPC Innovation Pharma, CSPC Pharmaceutical Group unit, forecasts H1 net profit at 1.18 billion-1.36 billion yuanPUBT·Jul 27 at 04:34 AM01093+0.12%300765+5.58%
Chinese biotech overtakes AI as emerging-market growth tradeBusinesstimes News·Jul 26 at 10:14 PM300765+5.58%AZN-1.13%
CSPC says China regulator grants breakthrough therapy designation for HER2-positive breast cancer comboPUBT·Jul 14 at 06:01 AM01093+0.12%300765+5.58%
Can AI collaborations power China’s next wave of blockbuster drug deals?SCMP·Jul 13 at 05:33 AM01093+0.12%03378-0.29%
CSPC PHARMA, AstraZeneca Forge Collaboration, Option and License Agreement for Development of siRNA DrugsAASTOCKS News·Jul 2 at 03:50 AM300765+5.58%AZN-1.13%
CSPC Pharma trustee buys 2,900,000 shares for HK$19.84 million under 2026 share award schemePUBT·Jun 23 at 06:04 AM300765+5.58%01093+0.12%
CSPC says Innovation unit files new Hong Kong listing application after prior lapsePUBT·Jun 22 at 03:39 AM01093+0.12%300765+5.58%
STOCKS | Four Companies File for Hong Kong IPOs, Including Transsion and Shijiazhuang Pharmaceutical InnovationCoinLive·Jun 19 at 05:24 AM688036-1.38%300765+5.58%
CSPC’s Efmedaglutide Alfa Wins Second NMPA Review for Type 2 DiabetesTip Ranks·Jun 18 at 05:17 AM01093+0.12%300765+5.58%
China’s drug makers are speeding up – will AI be their secret weapon?SCMP·Apr 18 at 03:04 AM09995+3.02%688331+1.95%
Beijing Stock Exchange Restarts Inquiry-Based Issuance After Three YearsWallstreetcn·Apr 10 at 07:16 AM300765+5.58%012370.00%
